Trends in Cardiovascular Medicine
Volume 15, Issue 8 , Pages 291-296 , November 2005

Apolipoprotein A-I Mimetic Peptides: Potential Role in Atherosclerosis Management

  • Prediman K. Shah

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Prediman K. Shah, MD, Room 5531, Division of Cardiology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA. Tel.: (+1)-310-423-3884; fax: (+1)-310-423-0144.
    • ,
  • Kuang-Yuh Chyu

References 

  1. Ameli S, Hultgardh-Nilsson A, Cercek B, et al. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation. 1994;90:1935–1941
  2. Amsterdam EA. Benefit on atherosclerosis of adding niacin in patients with low HDL-cholesterol taking a statin. Prev Cardiol. 2005;8:130
  3. Assmann G, Gotto AM. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109:III8–III14
  4. Barter P. HDL: a recipe for longevity. Atheroscler Suppl. 2004;5:25–31
  5. Bergt C, Pennathur S, Fu X, et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A. 2004;101:13032–13037
  6. Brewer HB. Increasing HDL cholesterol levels. N Engl J Med. 2004;350:1491–1494
  7. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583–1592
  8. Chiesa G, Sirtori CR. Apolipoprotein A-I(Milano): Current perspectives. Curr Opin Lipidol. 2003;14:159–163
  9. Datta G, Epand RF, Epand RM, et al. Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity. J Biol Chem. 2004;279:26509–26517
  10. de la Llera Moya M, Atger V, Paul JL, et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb. 1994;14:1056–1065
  11. Fazio S, Linton MF. The role of fibrates in managing hyperlipidemia: Mechanisms of action and clinical efficacy. Curr Atheroscler Rep. 2004;6:148–157
  12. Forrester JS, Makkar R, Shah PK. Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: An update for clinicians. Circulation. 2005;111:1847–1854
  13. Fournier N, de la Llera Moya M, Burkey BF, et al. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apoA-I transgenic rats. J Lipid Res. 1996;37:1704–1711
  14. Garber DW, Datta G, Chaddha M, et al. A new synthetic class a amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J Lipid Res. 2001;42:545–552
  15. Kozarsky KF, Donahee MH, Glick JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor–deficient mouse. Arterioscler Thromb Vasc Biol. 2000;20:721–727
  16. Li X, Chyu KY, Neto JR, et al. Differential effects of apolipoprotein A-I–mimetic peptide on evolving and established atherosclerosis in apolipoprotein E–null mice. Circulation. 2004;110:1701–1705
  17. Linsel-Nitschke P, Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov. 2005;4:193–205
  18. Mukherjee R, Strasser J, Jow L, et al. RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler Thromb Vasc Biol. 1998;18:272–276
  19. Navab M, Anantharamaiah GM, Hama S, et al. Oral administration of an Apo A-I mimetic Peptide synthesized from d-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 2002;105:290–292
  20. Navab M, Hama S, Hough G, et al. Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E–null mice. Circulation. 2003;108:1735–1739
  21. Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004;45:993–1007
  22. Navab M, Anantharamaiah GM, Reddy ST, et al. Oral D-4F causes formation of pre–beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E–null mice. Circulation. 2004;109:3215–3220
  23. Navab M, Anantharamaiah GM, Reddy ST, et al. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol. 2005;25:1325–1331
  24. Navab M, Anantharamaiah GM, Hama S, et al. D-4F and statins synergize to render HDL anti-inflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E null mice. Arterioscler Thromb Vasc Biol. 2005;25:1426–1432
  25. Navab M, Anantharamaiah GM, Reddy ST, et al. An oral apoJ peptide renders HDL anti-inflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E–null mice. Arterioscler Thromb Vasc Biol. 2005;25:1932–1937
  26. Navab M, Anantharamaiah GM, Reddy ST, et al. Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice. Circ Res. 2005;97(6):524–532
  27. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial. JAMA. 2003;290:2292–2300
  28. Ou J, Ou Z, Jones DW, et al. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Circulation. 2003;107:2337–2341
  29. Ou Z, Ou J, Ackerman AW, et al. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells. Circulation. 2003;107:1520–1524
  30. Remaley AT, Thomas F, Stonik JA, et al. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA-1 dependant and an ABCA-I independent pathway. J Lipid Res. 2003;44:828–836
  31. Shah PK, Nilsson J, Kaul S, et al. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E–deficient mice. Circulation. 1998;97:780–785
  32. Shah PK, Kaul S, Nilsson J, et al. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: An idea whose time for testing is coming, part II. Circulation. 2001;104:2498–2502
  33. Shah PK, Kaul S, Nilsson J, et al. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: An idea whose time for testing is coming, part I. Circulation. 2001;104:2376–2383
  34. Shah PK, Yano J, Reyes O, et al. High-dose recombinant apolipoprotein A-I(Milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e–deficient mice. Potential implications for acute plaque stabilization. Circulation. 2001;103:3047–3050
  35. Tangirala RK, Tsukamoto K, Chun SH, et al. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 1999;100:1816–1822
  36. UK Consensus . Role of fibrates in reducing coronary risk. Curr Med Res Opin. 2004;20:241–247
  37. Van Lenten BJ, Wagner AC, Anantharamaiah GM, et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation. 2002;106:1127–1132
  38. Van Lenten BJ, Wagner AC, Navab M, et al. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation. 2004;110:3252–3258
  39. Wallace JM, Schwarz M, Coward P, et al. Effects of peroxisome proliferator-activated receptor {alpha}/{delta} agonists on HDL-cholesterol in vervet monkeys. J Lipid Res. 2005;46:1009–1016

PII: S1050-1738(05)00179-9

doi: 10.1016/j.tcm.2005.09.003

Trends in Cardiovascular Medicine
Volume 15, Issue 8 , Pages 291-296 , November 2005

Article Tools

* Image Usage & Resolution